100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NR 566 Week 5 Assignment; Immunization - Pneumococcal 13-valent conjugate (PCV13) $13.63   Add to cart

Other

NR 566 Week 5 Assignment; Immunization - Pneumococcal 13-valent conjugate (PCV13)

 10 views  0 purchase
  • Course
  • Institution

Diptheria, tetanus & acellular pertussis (DTaP) Haemophilus influenza type b (Hib) Hepatitis B Human papillomavirus (HPV) Inactivated influenza (IIV) Inactivated poliovirus (IPV) Influenza recombinant (RIV) Live influenza (LAIV) Measles, mumps & rubella (MMR) Meningococcal serogroups A...

[Show more]

Preview 1 out of 4  pages

  • March 2, 2021
  • 4
  • 2020/2021
  • Other
  • Unknown
avatar-seller
1




Week 5: Immunization Paper Assignment 50 pts. 2-4 pages

Pneumococcal 13-valent conjugate (PCV13)


Pneumococcal 13-valent conjugate (PCV13) is a vaccine used for the prevention of

pneumonia caused by 13 different strands of pneumococcus (IBM Micromedex, 2020b). PCV13

has the trade name of Prevnar-13, and it is considered to be a conjugate vaccine. Meaning that

they are made up of two different components or fragments of the bacteria (USDHHS, 2020). It

is contraindicated with those who have previously had an allergic reaction or anaphylaxis to

Prevnar (IBM Micromedex, 2020b). In addition, if someone has had an adverse reaction to or

any diphtheria-toxoid–containing vaccine), including yeast (CDC, 2019). The administration

should be deferred in patients who already have pneumonia, unless it is determined by the

provider that the benefits outweigh the risks (IBM Micromedex, 2020b).

Common side effects include, erythema at the injection site, fatigue, joint pain, and

decreased sleep (IBM Micromedex, 2020b). Serious adverse effects can include, potential for

seizures, gastroenteritis, or pneumonia development (IBM Micromedex, 2020b). The minimum

age that a patient can start to receive this vaccine is 2 months of age (CDC, 2019). The

guidelines recommend that children receive a series of 4 doses, at 2 months, 4 months, 6 months

and 12-15 months (CDC, 2019). Special situations when patients are to receive Prevnar-13 are;

adults of 19-64 years of age, who are immunocompromised, a one-time dose is recommended.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Milestonee. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.63. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

79223 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.63
  • (0)
  Add to cart